Are HIS vendors a threat to PACS firms?The PACS marketplace has traditionally been a radiology-centric business. Hospital information systems vendors have for the most part watched the PACS game from the sidelines, perhaps due to wariness about
The PACS marketplace has traditionally been a radiology-centric business. Hospital information systems vendors have for the most part watched the PACS game from the sidelines, perhaps due to wariness about the large size of image data files, thorny communication service requirements, and their unfamiliarity with radiology departments. The technically demanding aspects of PACS have been best left to vendors accustomed to dealing with the needs of radiology, such as x-ray film or scanner modality vendors.
But HIS vendors are eyeing PACS as interest grows in the electronic medical record and integrated information and image management systems, and the need for these systems will only increase with the mushrooming of managed care and hospital networks. When HIS vendors begin offering PACS modules with their products, there is the definite possibility that hospitals may find this one-stop-shopping approach to information technology more attractive than being forced to buy separate IT components.
What role will PACS vendors play in this new environment? They will continue to thrive, because HIS vendors will still need the hard-earned years of expertise that PACS companies have acquired. Some PACS firms will likely partner with HIS vendors, while others will focus on radiology departments, which will remain a profitable business segment for the foreseeable future. Whatever the role, the demanding requirements of PACS ensure that vendors who have cut their teeth in this enigmatic market will not see their growing pains go for naught.
-Erik L. Ridley, Editor
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.